Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Reprod Immunol ; 48(6): 394-403, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12607776

RESUMO

PROBLEM: To determine the effect of ovarian stimulation on TH1, TH2 and natural killer (NK) lymphocytes, plasma cytokines, leptin and nitrite levels. METHODS: Women with reproductive failure were studied during the implantation window, at baseline (n = 18) and under ovarian stimulation (gonadotropins + progesterone, n = 6). CONTROLS: eight fertile women. Lymphocyte subpopulations and NK function were determined by flow cytometry. Interleukin-2 (IL-2), IL-4, IL-10, IFN-gamma, TNF-alpha, TGF-beta1 and leptin were measured by enzyme immunoassay (EIA); nitrite by the Griess reaction. RESULTS: At baseline, patients had higher values of NK effectors, NK activity and plasma IFN-gamma and IL-2 than controls. Conversely, TGF-beta1 values were lower. Hormones induced leukocytosis. Under stimulation, THI CD4+ cells, NK effectors and function and plasma IFN-gamma and IL-2 decreased, while transforming growth factor (TGF)-beta1 increased. Other variables did not change. CONCLUSION: The abnormal distribution of leukocytes, high TH1 cytokines and a low TGF-beta1 associated with reproductive failure, respond to ovarian stimulation, achieving total or partial normalization.


Assuntos
Gonadotropina Coriônica/farmacologia , Citocinas/sangue , Infertilidade Feminina/terapia , Células Matadoras Naturais/efeitos dos fármacos , Leptina/sangue , Leuprolida/farmacologia , Nitritos/sangue , Indução da Ovulação , Progesterona/farmacologia , Células Th1/efeitos dos fármacos , Células Th2/efeitos dos fármacos , Adulto , Citotoxicidade Imunológica , Feminino , Humanos , Imunofenotipagem , Infertilidade Feminina/sangue , Infertilidade Feminina/imunologia , Interferon gama/sangue , Interleucina-10/sangue , Interleucina-2/sangue , Interleucina-4/sangue , Células Matadoras Naturais/imunologia , Contagem de Linfócitos , Fator de Crescimento Transformador beta/sangue , Fator de Crescimento Transformador beta1 , Fator de Necrose Tumoral alfa/análise
2.
Clin Diagn Lab Immunol ; 8(5): 1036-8, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11527826

RESUMO

In patients with chronic paracoccidioidomycosis (n = 10), levels of tumor necrosis factor alpha, interleukin-10, and interleukin-2 in serum, measured by enzyme-linked immunosorbent assay (in picograms per milliliter, as mean +/- standard error of the mean), were higher than in normal controls (n = 8): 186 +/- 40 versus 40 +/- 7 (P < 0.05), 203 +/- 95 versus 20 +/- 8 (P = 0.001), and 96.3 +/- 78.57 versus 1.19 +/- 1.19 (P = 0.045), respectively. Gamma interferon and interleukin-4 levels were similar in patients and controls.


Assuntos
Interleucina-10/sangue , Paracoccidioidomicose/imunologia , Fator de Necrose Tumoral alfa/metabolismo , Adulto , Idoso , Animais , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Paracoccidioidomicose/sangue
3.
J Endovasc Ther ; 8(2): 114-24, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11357969

RESUMO

PURPOSE: To examine the inflammatory impact of endovascular and conventional surgery of abdominal aortic aneurysm (AAA) as assessed by the activation of neutrophils and serum levels of pro- and anti-inflammatory cytokines. METHODS: Twenty-four patients undergoing AAA exclusion were treated with either endovascular (n = 14) or conventional (n=10) techniques. Clinical and hematological data, respiratory burst of neutrophils, and the expression of adhesion and activation molecules (CD18, CD11b, CD69, and HLA-DR) were analyzed by flow cytometry. The enzyme-linked immunosorbent assay technique was used to measure proinflammatory cytokine interleukin (IL)-8 and anti-inflammatory cytokines IL-1 receptor antagonist (IL-1RA) and transforming growth factor beta1 (TGF-beta1). RESULTS: All patients, most of whom had normal cytokine values before surgery, were successfully treated. No significant changes were found in surface antigens. Basal respiratory burst was quite heterogeneous; in all cases respiratory burst activity decreased after surgery and remained low throughout the observation period. Despite marked interpatient differences, IL-1RA and IL-8 increased after surgery, whereas TGF-beta1 decreased, although the variation achieved statistical significance only in the conventional group. Elevated IL-1RA returned to normal within 48 hours in the endoluminal group, whereas the level remained high in the conventional group in the last sample. CONCLUSIONS: Despite heterogeneity before surgery, the respiratory burst decreased for most of the patients regardless of the approach, and both techniques increased IL-1RA. Although both procedures seemed to decrease TGF-beta1, the difference was significant only with the conventional approach. IL-1RA levels fell toward basal values quicker in the endograft patients, suggesting that the endoluminal approach was less aggressive.


Assuntos
Angioplastia , Aneurisma da Aorta Abdominal/cirurgia , Citocinas/sangue , Neutrófilos/metabolismo , Explosão Respiratória/fisiologia , Idoso , Idoso de 80 Anos ou mais , Sedimentação Sanguínea , Proteína C-Reativa/metabolismo , Feminino , Humanos , Proteína Antagonista do Receptor de Interleucina 1 , Masculino , Pessoa de Meia-Idade , Sialoglicoproteínas/sangue , Fator de Crescimento Transformador beta/sangue , Fator de Crescimento Transformador beta1 , Resultado do Tratamento
4.
Immunol Lett ; 75(2): 137-41, 2001 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-11137138

RESUMO

VRCTC-310-Onco (crotoxin, a secretory phospholipase A2+cardiotoxin) is under development as an anti-neoplastic agent. Pro-inflammatory cytokines TNF-alpha and interleukin 1 alpha (IL-1alpha) and anti-inflammatory cytokine IL-1 receptor antagonist (IL-1ra) were measured with commercial ELISA kits in sera corresponding to 23 cycles with doses between 0.0025 and 0.023 microg/kg body weight, obtained during the phase I trial of VRCTC-310-Onco. Neither serum TNF-alpha nor IL-1alpha did change significantly after VRCTC-310-Onco. Basal IL-1ra was 794 +/- 97 pg/ml, by 3 h it was similar, 651 +/- 99 pg/ml and at 24 h p.i. it increased to 1197 +/- 122 pg/ml (P<0.001). The increase was dose-dependent. The addition of dexamethasone (required to reduce pain with the highest doses) inhibited IL-1alpha and enhanced the induction of IL-1ra by VRCTC-310-Onco. Summing up, in vivo, in humans, in the dose range tested, VRCTC-310-Onco induces IL-1ra, and does not consistently modify IL-1alpha or TNF-alpha serum levels.


Assuntos
Proteínas Cardiotóxicas de Elapídeos/farmacologia , Crotoxina/farmacologia , Interleucina-1/sangue , Fosfolipases A/farmacologia , Sialoglicoproteínas/sangue , Fator de Necrose Tumoral alfa/metabolismo , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacologia , Proteínas Cardiotóxicas de Elapídeos/administração & dosagem , Dexametasona/administração & dosagem , Feminino , Humanos , Mediadores da Inflamação/sangue , Proteína Antagonista do Receptor de Interleucina 1 , Neoplasias/tratamento farmacológico , Neoplasias/imunologia , Fosfolipases A/administração & dosagem , Fosfolipases A2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...